Lynn M. Pouliot
Affiliations: | 2012 | Microbiology & Immunology | Georgetown University, Washington, DC |
Google:
"Lynn Pouliot"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Michael M. Gottesman | grad student | 2012 | Georgetown | |
| (MicroRNA involvement in the cisplatin-selected pleiotropic multidrug-resistant phenotype.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Fung KL, Tepede AK, Pluchino KM, et al. (2014) Uptake of compounds that selectively kill multidrug-resistant cells: the copper transporter SLC31A1 (CTR1) increases cellular accumulation of the thiosemicarbazone NSC73306. Molecular Pharmaceutics. 11: 2692-702 |
| Pouliot LM, Shen DW, Suzuki T, et al. (2013) Contributions of microRNA dysregulation to cisplatin resistance in adenocarcinoma cells. Experimental Cell Research. 319: 566-74 |
| Pouliot LM, Chen YC, Bai J, et al. (2012) Cisplatin sensitivity mediated by WEE1 and CHK1 is mediated by miR-155 and the miR-15 family. Cancer Research. 72: 5945-55 |
| Shen DW, Pouliot LM, Hall MD, et al. (2012) Cisplatin resistance: a cellular self-defense mechanism resulting from multiple epigenetic and genetic changes. Pharmacological Reviews. 64: 706-21 |
| Shen DW, Pouliot LM, Gillet JP, et al. (2012) The transcription factor GCF2 is an upstream repressor of the small GTPAse RhoA, regulating membrane protein trafficking, sensitivity to doxorubicin, and resistance to cisplatin. Molecular Pharmaceutics. 9: 1822-33 |
| Pouliot LM, Bai J, Hall MD, et al. (2012) Abstract B12: The miR-15 family and miR-155 mediate WEE1 and CHEK1 effects on cisplatin-resistance in cancer cells Cancer Research. 72: B12-B12 |